Iqvia

(jirawut seepukdee/iStock via Getty Images Plus)

Tech Innovations: August 2022

By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

(Andrey Suslov/iStock via Getty Images Plus)

Tech Innovations: March 2022

By Jenni Spinner

The latest news on software, manufacturing solutions, partnerships, and more includes IQVIA, TFF Pharmaceuticals, Quotient Sciences and other key companies.

(alphaspirit/iStock via Getty Images Plus)

IQVIA completes acquisition of Q2 Diagnostics

By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

(Image: Getty/DragonImages)

Iqvia: Trials must ease patient burdens

By Jenni Spinner

The health information technology company is looking at ways to alleviate the burdens clinical trial participants face, in order to improve recruitment and retention.

(Image: Getty/Zolnierek)

Veeva files motion to expand suit against Iqvia

By Jenni Spinner

Filed in 2017, Veeva Systems’ antitrust lawsuit alleges Iqvia has exacted ‘monopoly control’ restricting freedom in clinical trial software and data management.

(Image: Getty/BrianAJackson)

FDA guidance ‘a step in the right direction’

By Melissa Fassbender

The FDA has published the second in a series of guidance documents that aim to accelerate research and the use of patient input to inform clinical development programs, says Iqvia head.

(Image: Getty/DGLimages)

Iqvia leads $14m investment round in patient engagement app

By Melissa Fassbender

Belong.Life raises $14m as part of a Series B funding round with plans to expand its patient engagement platform, using and complementing Iqvia’s solutions “to transform patient engagement,” says Iqvia VP.

(Image: Getty/berya113)

Iqvia ‘unchallenged’ leads RWE market: Report

By Melissa Fassbender

Iqvia leads the real world evidence market, which is at an inflection point, as pharma furthers its investment and vendors improve capabilities, according to a recent report.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All